Free beta — full access, free until October 2026. No card, no auto-charge — paid plans are opt-in when they launch.
Company
Mosaic ImmunoEngineering Inc. (CPMV)
Standardized SEC financial data for Mosaic ImmunoEngineering Inc. — income statement, balance sheet, cash flow and 40+ ratios, available as a clean JSON API. CIK 0000836564 · OTC · Biological Products, (No Diagnostic Substances).
Return on equity
9.2%
Free cash flow
-$111K
Current ratio
0.00×
EPS (diluted)
$-0.10
Income statement
USD
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
R&D expense
—
$1.5M
$1.0M
$435K
$184K
$64K
SG&A expense
$996K
$2.0M
$1.6M
$964K
$696K
$552K
Operating income
—
-$3.5M
-$2.6M
-$1.4M
-$880K
-$616K
Interest expense
—
$0
Standardized from Mosaic ImmunoEngineering Inc.'s SEC filings — per-share figures split-adjusted. Full history via the API.